系统开发和优化微流体配方协议的脂质体亚胺酸的系统开发和优化
Abdullah A Masud1, Nabilah Ibnat1, Areli Medina Hernandez1
1Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky Lexington KY 40536 USA Vincent.venditto@uky.edu.
RSC pharmaceutics
|November 24, 2025
概括
微流体纳米沉提供了一种可扩展的方法,用于生产脂体亚胺素 (L-AZM),用于治疗心脏损伤. 与传统方法相比,这种优化的L-AZM配方显示出更好的质量属性,为临床使用铺平了道路.
科学领域:
- 制药科学 制药科学
- 纳米技术纳米技术
- 心血管研究研究心血管研究
背景情况:
- 脂质体亚胺素 (L-AZM) 在心肌梗塞后治疗心脏损伤方面表现有前途.
- 对于L-AZM生产的传统薄膜水化 (TFH) 面临着可扩展性和可重复性问题,阻碍了临床转化.
研究的目的:
- 用微流体纳米沉来优化脂质体亚胺素 (L-AZM) 配方,以改善制造和临床适用性.
- 与TFH相比,通过微流体生产的L-AZM的关键质量属性 (CQAs) 的评估.
主要方法:
- 系统优化微流体纳米沉参数 (流速比,总流速).
- 使用DSPC:DSPG:Chol:AZM摩尔比率进行配方调整.
- 评估脂质体大小,多分散性指数 (PDI),封装效率和泄漏.
- 微流体和TFH方法之间的体外巨细胞极化活性的比较.
主要成果:
- 最佳的微流体参数确定为 4:1 流量比和 10 mL/分钟总流量.
- 与TFH相比,一个优化的配方 (DSPC:DSPG:Chol:AZM 1:1:1:0.5) 显示了较小的尺寸和PDI.
- 两种配方方法之间在体外巨细胞极化活性上没有显著差异.
结论:
- 微流体纳米沉为生产具有增强质量属性的L-AZM提供了一种可复制和可扩展的方法.
- 优化的L-AZM配方适合进一步的临床前开发和潜在的临床转换用于心肌梗塞治疗.
- 这项研究为先进的脂质体药物递送系统建立了制造途径.
更多相关视频
08:44Preparation, Administration, and Assessment of In Vivo Tissue-Specific Cellular Uptake of Fluorescent Dye-Labeled Liposomes
Published on: July 30, 2020
5.3K
09:41Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform
Published on: February 25, 2021
24.9K
相关概念视频
Amino Acid Biosynthetic Pathways
Amino acid biosynthesis is essential for cell growth, protein synthesis, and metabolic regulation. Cells generate essential and non-essential amino acids from metabolic intermediates to sustain vital biological functions. These intermediates originate from key metabolic pathways: glycolysis, the tricarboxylic acid (TCA) cycle, and the pentose phosphate pathway. Important precursors include α-ketoglutarate, pyruvate, oxaloacetate, phosphoenolpyruvate, and erythrose-4-phosphate, which provide...
Bioreactor Design and Operational System
Bioreactors are engineered vessels designed to cultivate microorganisms under controlled conditions for industrial bioprocessing. They maintain sterility and allow precise regulation of pH, temperature, oxygen, and nutrient levels to optimize microbial growth and metabolite production. Bioreactors range from small laboratory units of 1 liter to industrial systems holding up to 500,000 liters, though only about 75% of their volume is actively used for fermentation. The remaining headspace...
